Cerity Partners LLC Has $6.37 Million Stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Cerity Partners LLC increased its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 24.2% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 67,896 shares of the company's stock after buying an additional 13,228 shares during the period. Cerity Partners LLC's holdings in GE HealthCare Technologies were worth $6,372,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Certified Advisory Corp lifted its position in shares of GE HealthCare Technologies by 69.9% during the 3rd quarter. Certified Advisory Corp now owns 4,642 shares of the company's stock worth $436,000 after purchasing an additional 1,910 shares during the last quarter. Leelyn Smith LLC acquired a new position in shares of GE HealthCare Technologies during the third quarter worth approximately $3,845,000. Nwam LLC bought a new stake in shares of GE HealthCare Technologies in the third quarter valued at approximately $227,000. Raymond James Trust N.A. increased its position in GE HealthCare Technologies by 40.0% during the third quarter. Raymond James Trust N.A. now owns 32,131 shares of the company's stock worth $3,016,000 after acquiring an additional 9,185 shares during the period. Finally, Otter Creek Advisors LLC raised its stake in GE HealthCare Technologies by 178.0% during the 3rd quarter. Otter Creek Advisors LLC now owns 53,996 shares of the company's stock valued at $5,068,000 after purchasing an additional 34,570 shares during the last quarter. 82.06% of the stock is currently owned by institutional investors and hedge funds.

GE HealthCare Technologies Price Performance

Shares of GEHC traded up $0.49 on Thursday, hitting $83.00. The company's stock had a trading volume of 1,807,975 shares, compared to its average volume of 3,079,142. The company has a market capitalization of $37.92 billion, a PE ratio of 22.80, a PEG ratio of 2.96 and a beta of 1.24. GE HealthCare Technologies Inc. has a fifty-two week low of $66.39 and a fifty-two week high of $94.55. The company has a 50 day moving average price of $88.07 and a 200 day moving average price of $83.61. The company has a debt-to-equity ratio of 1.12, a current ratio of 1.23 and a quick ratio of 0.98.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last posted its quarterly earnings data on Wednesday, October 30th. The company reported $1.14 earnings per share for the quarter, beating the consensus estimate of $1.06 by $0.08. GE HealthCare Technologies had a net margin of 8.56% and a return on equity of 25.19%. The firm had revenue of $4.86 billion during the quarter, compared to analysts' expectations of $4.87 billion. During the same quarter last year, the company posted $0.99 EPS. The company's quarterly revenue was up .9% compared to the same quarter last year. On average, research analysts anticipate that GE HealthCare Technologies Inc. will post 4.3 earnings per share for the current fiscal year.

GE HealthCare Technologies Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 14th will be given a dividend of $0.035 per share. The ex-dividend date is Tuesday, January 14th. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.17%. This is an increase from GE HealthCare Technologies's previous quarterly dividend of $0.03. GE HealthCare Technologies's payout ratio is presently 3.30%.

Insider Activity

In related news, CEO Roland Rott sold 3,577 shares of the business's stock in a transaction that occurred on Wednesday, November 6th. The shares were sold at an average price of $86.48, for a total transaction of $309,338.96. Following the completion of the sale, the chief executive officer now directly owns 24,298 shares of the company's stock, valued at $2,101,291.04. The trade was a 12.83 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. 0.27% of the stock is currently owned by insiders.

Analysts Set New Price Targets

GEHC has been the topic of several research analyst reports. JPMorgan Chase & Co. began coverage on shares of GE HealthCare Technologies in a research report on Monday, September 9th. They issued a "neutral" rating and a $90.00 price target on the stock. Wells Fargo & Company lifted their price objective on GE HealthCare Technologies from $95.00 to $96.00 and gave the stock an "overweight" rating in a report on Thursday, October 31st. UBS Group lowered GE HealthCare Technologies from a "neutral" rating to a "sell" rating and cut their target price for the company from $84.00 to $74.00 in a research note on Thursday, September 26th. BTIG Research raised shares of GE HealthCare Technologies from a "neutral" rating to a "buy" rating and set a $100.00 price objective for the company in a report on Wednesday, September 18th. Finally, Evercore ISI upped their target price on shares of GE HealthCare Technologies from $98.00 to $102.00 and gave the company an "outperform" rating in a research note on Tuesday, October 1st. One analyst has rated the stock with a sell rating, five have issued a hold rating, eight have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $94.36.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.